Influenza vaccination for heart failure patients: a cost-effectiveness analysis from the perspective of chinese healthcare system

HIGHLIGHTS

• What: Based on the trial, this study aims to develop a mathematical model and assess the cost and effectiveness of influenza vaccination for HF patients in China. This study determined that the HRQoL utility scores for patients categorized by NYHA functional class were as follows: 0.732 for NYHA I, 0.78 for NYHA II, 0.715 for NYHA III, and 0.66 for NYHA IV. The authors still hold the belief that this research is useful for policymakers, providing stable and conservative results. frontiersin.org 10.3389/fpubh.2024.1348207 Cost effectiveness acceptability curve.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.